Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Raccoon eyes in an infant with neuroblastoma.
Onoda T, Sato H, Meguro T, Mitsui T. Onoda T, et al. Among authors: meguro t. Pediatr Int. 2021 Jul;63(7):863-864. doi: 10.1111/ped.14618. Pediatr Int. 2021. PMID: 34219341 No abstract available.
ALOX12 mutation in a family with dominantly inherited bleeding diathesis.
Mitsui T, Makino S, Tamiya G, Sato H, Kawakami Y, Takahashi Y, Meguro T, Izumino H, Sudo Y, Norota I, Ishii K, Hayasaka K. Mitsui T, et al. Among authors: meguro t. J Hum Genet. 2021 Aug;66(8):753-759. doi: 10.1038/s10038-020-00887-6. Epub 2021 Feb 10. J Hum Genet. 2021. PMID: 33564083
A surgical case of pediatric spinal medulloepithelioma.
Nakamura K, Matsuda KI, Kabasawa T, Meguro T, Kurose A, Sonoda Y. Nakamura K, et al. Among authors: meguro t. Childs Nerv Syst. 2022 Feb;38(2):473-477. doi: 10.1007/s00381-021-05293-7. Epub 2021 Jul 26. Childs Nerv Syst. 2022. PMID: 34312708
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
Honda Y, Muramatsu H, Nanjo Y, Hirabayashi S, Meguro T, Yoshida N, Kakuda H, Ozono S, Wakamatsu M, Moritake H, Yasui M, Sano H, Manabe A, Sakashita K. Honda Y, et al. Among authors: meguro t. Int J Hematol. 2022 Feb;115(2):263-268. doi: 10.1007/s12185-021-03248-x. Epub 2021 Oct 29. Int J Hematol. 2022. PMID: 34714526
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
Sho T, Suda G, Ohara M, Kohya R, Sasaki T, Yoshida S, Hosoda S, Ogawa K, Kitagataya T, Maehara O, Ohnishi S, Kawagishi N, Natsuizaka M, Nakai M, Baba M, Yamamoto Y, Tsukuda Y, Meguro T, Yamada R, Kobayashi T, Takagi T, Sakamoto N; NORTE STUDY GROUP. Sho T, et al. Among authors: meguro t. Target Oncol. 2024 Sep;19(5):769-778. doi: 10.1007/s11523-024-01092-7. Epub 2024 Sep 2. Target Oncol. 2024. PMID: 39222223
410 results